Holen Sie sich die Stockscreener-App
1.01
1.00%
0.01
Handel nachbörslich:
1.01
Tevogen Bio Holdings Inc Aktie (TVGN) Neueste Nachrichten
Tevogen Bio Holdings Inc. SEC 10-K Report - TradingView
Tevogen Bio Holdings Delays Annual Report Filing - TipRanks
Thomas Butler steps down as Biomea CEO - biocentury.com
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast - The Manila Times
Tevogen Bio's Ambitious $2B Revenue Target Backed by Leadership Excellence and Key Hire - Stock Titan
Tevogen Bio appoints new head of government affairs By Investing.com - Investing.com South Africa
Tevogen Bio appoints new head of government affairs - Investing.com
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan - Quantisnow
Tevogen Bio Appoints David E. Banko as Global Head of - GlobeNewswire
Healthcare Access Expert Joins Tevogen Bio to Accelerate Multi-Therapeutic Commercial Launch - Stock Titan
TSX Continues Higher as U.S. Trade Policy Appears to Soften - The Globe and Mail
SPY ETF News, 3/21/2025 - The Globe and Mail
Meta Stock Dips Below $600: A Buying Opportunity or a Red Flag? - The Globe and Mail
Tevogen Bio CEO reinforces commitment to retention of equity capital - MSN
Tevogen Bio’s chief scientific officer sells $253,935 in stock By Investing.com - Investing.com Australia
Tevogen bio’s chief scientific officer sells $253,935 in stock By Investing.com - Investing.com Australia
Tevogen Bio’s chief scientific officer sells $253,935 in stock - Investing.com India
Tevogen bio’s chief scientific officer sells $253,935 in stock - Investing.com
Tevogen Bio Holdings Officer Sells Shares to Cover Tax Obligations - TradingView
Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Short Interest Down 86.7% in February - Defense World
Tevogen Bio (NASDAQ:TVGN) Receives “Buy” Rating from D. Boral Capital - Defense World
Public market insider selling at Aura Minerals (ORA) - The Globe and Mail
Tevogen bio’s chief scientific officer sells shares worth $231,734 By Investing.com - Investing.com South Africa
Tevogen bio’s chief scientific officer sells shares worth $231,734 - Investing.com India
Tevogen Bio Files New US Patent for T Cell Vaccine Under Development -March 10, 2025 at 01:19 pm EDT - Marketscreener.com
Tevogen announces new patent filed for T cell vaccine - TipRanks
Tevogen Bio Announces Unique T Cell Vaccine Under Development & Files Patent With USPTO - Marketscreener.com
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO - The Manila Times
Tevogen Bio Files Patent for Innovative T Cell Vaccine Targeting Entire Viral Genome to Combat Mutations - Nasdaq
Tevogen Bio Files Patent for AI-Powered T Cell Vaccine with Military Applications - StockTitan
Have Tevogen Bio Holdings Insiders Been Selling Stock? - simplywall.st
Tevogen Bio Holdings Inc. (TVGN) Secures $8M Grant, Accelerates AI Initiatives with Microsoft - Insider Monkey
Tevogen bio’s chief scientific officer sells shares totaling $250k By Investing.com - Investing.com South Africa
Tevogen Bio's CIO Mittul Mehta Discusses AI Innovations in Biotech at Proskauer Panel - Nasdaq
Tevogen Bio’s CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer’s AI Discussion Panel - GlobeNewswire
Can AI Transform Biotech? Tevogen's Tech Chief Reveals Next-Gen Strategy - StockTitan
Tevogen Bio’S CIO & Head Of Tevogen.AI, Mittul Mehta, Featured Speaker At Proskauer’S AI Discussion Panel - MENAFN.COM
Tevogen bio’s chief scientific officer sells shares totaling $250k - Investing.com
9 AI News Updates Investors Should Not Miss - Insider Monkey
D. Boral Capital Begins Coverage on Tevogen Bio (NASDAQ:TVGN) - Defense World
Analyzing Tevogen Bio (NASDAQ:TVGN) and Qiagen (NYSE:QGEN) - Defense World
Tevogen Bio's T-Cell Therapy Approach Stands Out, Analyst Sees Strong Potential - Benzinga
This Tevogen Bio Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga India
Tevogen initiated with a Buy at D. Boral Capital - TipRanks
Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations - GlobeNewswire
Tevogen Bio To Receive $8 Mln Of Non-Dilutive Grant Funding - MarketScreener
Tevogen Bio Secures Additional $8 Million Grant from KRHP LLC to Advance AI-Driven Immunotherapy Developments - Nasdaq
How Tevogen Bio's $8M Grant Funding Strengthens Its AI-Powered Biotech Future - StockTitan
10.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):